Document Detail

Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents.
MedLine Citation:
PMID:  12732447     Owner:  NLM     Status:  MEDLINE    
Restenosis is the principal drawback of percutaneous coronary procedures. Until now, the only widely accepted way to reduce restenosis rate has been the stent. However, clinical restenosis still represents the major limitation of this technology. This article summarizes recent laboratory and clinical investigations concerning the mechanisms responsible for the transmission of mitogenic signals from plasma membrane to the nucleus in vascular smooth muscle cells that determine neointima formation after stent deployment. Recent experimental data on the impact of diabetes and physical exercise on restenosis also is reviewed. Finally, the new concept of local drugs that elute directly to the site of vascular injury from coated stents and the available clinical results obtained with rapamycin or paclitaxel-eluting stents are discussed.
Ciro Indolfi; Annalisa Mongiardo; Antonio Curcio; Daniele Torella
Related Documents :
3941217 - Noninvasive identification of left main and triple vessel coronary artery disease: impr...
18098237 - Randomized, placebo-controlled, double-blind pilot trial of ramipril in mcardle's disease.
12732447 - Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents.
9193037 - Measurement of coronary blood flow velocity during handgrip exercise using breath-hold ...
15795817 - Cardiac mitochondrial respiratory function and oxidative stress: the role of exercise.
23639367 - The normandy field study on juvenile osteochondral conditions: conclusions regarding th...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Trends in cardiovascular medicine     Volume:  13     ISSN:  1050-1738     ISO Abbreviation:  Trends Cardiovasc. Med.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-06     Completed Date:  2003-09-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9108337     Medline TA:  Trends Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  142-8     Citation Subset:  IM    
Division of Cardiology, Magna Graecia University, Catanzaro, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary
Blood Vessel Prosthesis Implantation
Coated Materials, Biocompatible / therapeutic use*
Coronary Restenosis / etiology*,  physiopathology,  therapy*
Muscle, Smooth, Vascular / cytology,  physiopathology
Signal Transduction / physiology
Reg. No./Substance:
0/Coated Materials, Biocompatible

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pathophysiology of human genetic CD36 deficiency.
Next Document:  A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced p...